PAI-1, a key inhibitor of the fibrinolytic system, has been implicated in various disorders, including thrombosis, systemic lupus erythematosus, thyroid eye disease, and metabolic syndrome. This evidence concerns the gene SERPINE1 and systemic lupus erythematosus.